-
Acorda Therapeutics (NASDAQ:ACOR) versus Monte Rosa Therapeutics (NASDAQ:GLUE) Head-To-Head Contrast
05 May 2023 06:15 GMT
… strength of their profitability, dividends, analyst recommendations, risk, … Therapeutics is more favorable than Acorda Therapeutics.
Earnings & Valuation … Boston, Massachusetts.
About Acorda Therapeutics
(Get Rating)
Acorda Therapeutics, Inc. engages in …
-
Featured Company News – Acorda Therapeutics Adopts Poison Pill
05 Sep 2017 11:43 GMT
… news making the headlines for Acorda Therapeutics, Inc. (NASDAQ: ACOR), following … The Company also declared a dividend distribution of one preferred … its expiration.
About Acorda Therapeutics, Inc.
Established in 1995, Acorda Therapeutics is a biotechnology …
-
Us Bancorp \de\ Buys iShares International Select Dividend, Vanguard Intermediate-Term Bond, Schwab U.S. REIT, Sells Red Hat Inc, Best Buy Co Inc, Tennant Co
09 May 2019 01:51 GMT
… de\ buys iShares International Select Dividend, Vanguard Intermediate-Term Bond, Schwab … Grill Inc, Itau Corpbanca, Acorda Therapeutics Inc, BlackRock MuniHoldings Quality Fund … , Invesco Preferred, Invesco International Dividend Achievers ETF, Invesco S…
-
Biogen (NASDAQ:BIIB) versus SAB Biotherapeutics (NASDAQ:SABS) Head to Head Analysis
19 Oct 2023 12:04 GMT
… on the strength of their dividends, analyst recommendations, valuation, profitability, institutional … collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited …
-
Prime Medicine (NYSE:PRME) and Biogen (NASDAQ:BIIB) Financial Review
20 Oct 2023 15:05 GMT
… their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership … collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited …
-
Comparing Biogen (NASDAQ:BIIB) & Beam Therapeutics (NASDAQ:BEAM)
24 Sep 2023 22:58 GMT
… the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability … collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited …
-
3 Biotech Stocks to Buy under $20
11 Sep 2023 19:59 GMT
… biotech stocks MacroGenics, Inc. (MGNX), Acorda Therapeutics, Inc. (ACOR), and Shionogi … With a four-year average dividend yield of 1.80%, SGIOY … pays an annual dividend of $0.24, which … translates to a dividend yield of 2.41% on …
-
Reviewing Mayne Pharma Group (OTCMKTS:MAYNF) and Biogen (NASDAQ:BIIB)
03 Sep 2023 13:22 GMT
… the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability … collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited …
-
Iovance Biotherapeutics (NASDAQ:IOVA) and Biogen (NASDAQ:BIIB) Critical Analysis
04 Jan 2023 07:13 GMT
… the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability … collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited …
About
© 1995-2025